Study warns of Alzheimer's risk in some prostate cancer drugs Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer’s disease as those using other treatments, according to an analysis of electronic medical records published Monday.
Mother and daughter battling breast cancer share pain of watching loved one suffer In between the seamless stream of conversation between mother and daughter—jumping from holiday gifts for the children to the adults’ lifetime Girl Scouts membership—they chat about their breast cancers.
Organizations issue joint guidelines for breast cancer survivors Most breast cancer survivors require routine mammograms and physical exams to check for new tumors, but they don't need additional imaging or lab tests unless symptoms suggest malignancies may have returned, according to new joint guidelines from two leading U.S. cancer groups.
Scientists assembled for Monsanto say herbicide not carcinogenic, disputing WHO report A panel of scientists is disputing a World Health Organization report published earlier this year that concluded glyphosate, the world's most widely used weed killer and main ingredient in Monsanto Co's Roundup herbicide, is probably carcinogenic to humans.
Melanoma experts optimistic about Jimmy Carter's progress Former President Jimmy Carter said Sunday that his latest brain scan found no evidence of melanoma, the serious form of cancer that doctors discovered this summer in his liver and brain.
Gilead leukemia drug trial unblinded early due to success A late stage trial of a Gilead Sciences drug in previously treated patients with a particular type of leukemia was unblinded early after independent monitors determined the medicine provided significant benefit in delaying worsening of the disease, the company said on Monday.
J&J leukemia drug cuts death risk vs. chemo in new patients, study finds Johnson & Johnson's and AbbVie's cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine.
Risk of death nearly doubled for Vietnam veterans with PTSD Higher than average death rates among Vietnam War veterans with post-traumatic stress disorder (PTSD) suggest that combat trauma may still be affecting veterans' health even decades after the war, according to a new study.
